Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational - Identifying and Validating Novel Mechanisms of Radiation Resistance in Rhabdomyosarcoma

NCT01626170 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01626170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01626170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational - Identifying and Validating Novel Mechanisms of Radiation Resistance in Rhabdomyosarcoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
Not reported
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar childhood rhabdomyosarcoma, embryonal childhood rhabdomyosarcoma, previously treated childhood rhabdomyosarcoma, previously untreated childhood rhabdomyosarcoma, recurrent childhood rhabdomyosarcoma